Bicara Therapeutics Inc. (BCAX) (CIK 0002023658) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001193125-25-293647
- Form
- CORRESP
- Filer
- Bicara Therapeutics Inc. (BCAX) (CIK 0002023658)
- CIK
- 0002023658
- Ticker
- BCAX
- Filed
- 2025-11-24
- SIC industry
- 2834
- HQ
- Boston, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/2023658/000119312525293647/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗